课题基金 / 基金详情

Small Animal Studies Core

Small Animal Studies Core
小动物研究核心
批准号:
10328522
负责人:
Anna M Wu
金额:
$6.27万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 2023-03-31
关键词:
Advanced DevelopmentAdvisory CommitteesAnimal ExperimentationAnimal ExperimentsAnimal ModelAnimalsAntineoplastic AgentsBioluminescenceBrainBreastCancer BiologyCancer Center Support GrantCell physiologyCity of Hope Comprehensive Cancer CenterClinicClinicalCollaborationsColorectalColorectal CancerComputer softwareConsultConsultationsDataData AnalysesData CollectionDevelopmentDiagnosisDirect CostsDrug Delivery SystemsEducationEnsureEquipmentEvaluationFacultyFeedbackFluorescenceFundingGoalsGrantGuidelinesHazardous SubstancesHematologic NeoplasmsHematopoietic NeoplasmsHepatocyteHumanHuntington DiseaseIACUCImageImaging DeviceImaging TechniquesImaging technologyImmune systemImmunoPETImmunodeficient MouseIndividualInfectionKidneyLaboratoriesLiverLungMaintenanceMedicineModelingMolecularMolecular ImmunologyMonitorMonoclonal AntibodiesMultimodal ImagingNCI Center for Cancer ResearchPancreasPeer ReviewPerformancePharmaceutical PreparationsPhysiciansPositron-Emission TomographyPostdoctoral FellowPredispositionPreparationProceduresProstateProtocols documentationRadiationRadioactiveRadiolabeledRadionuclide ImagingReagentReportingResearchResearch PersonnelResearch SupportResource SharingResourcesScheduleScientistServicesSolid NeoplasmSupport SystemSurveysSystemTechniquesTherapeutic AgentsToxic effectTrainingTranslatingUnited States National Institutes of HealthXenograft ModelXenograft procedureanimal imaginganimal resourceanticancer researchbasecancer immunotherapycomparativecost effectivedesigndrug developmentdrug metabolismexperimental studyhumanized mouseimaging studyin vivoin vivo imagingindividual patientinstrumentinstrumentationinvestigator trainingleukemia/lymphomalung sarcomamalignant stomach neoplasmmembermodel designmouse modelneoplastic cellnext generationnoveloperationoptical imagingorganizational structurepatient derived xenograft modelpharmacokinetics and pharmacodynamicspre-clinicalprecision medicinepreclinical studyprofessorresearch and developmentresponseservice deliverysingle photon emission computed tomographysquare footstem cell therapytargeted agenttheoriestheranosticstherapeutic developmenttranslational cancer researchtreatment responsetumortumor growth

项目摘要

项目成果

Anna M Wu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Small Animal Studies Core Shared Resource ABSTRACT The Small Animal Studies Core (SASC) combines the resources available through the previously reviewed Small Animal Imaging Core with a new Animal Tumor Models component. This combined resource provides exceptional quality services for City of Hope Comprehensive Cancer Center (COHCCC) members for basic and translational preclinical studies in cancer biology, anti-cancer drug development, and stem cell therapeutic development. The Small Animal Imaging component of the SASC provides consultation, advanced imaging equipment, imaging services, hands-on training for COHCCC members, and support for protocol and grant preparation. Current systems in the Imaging Laboratory include two units for bioluminescence/fluorescence optical imaging (Ami X and Lago X from Spectral Instruments Imaging) and a PET/SPECT/CT trimodal scanner (Inveon from Siemens). These systems support molecular-based imaging to allow for the monitoring of cellular processes and the non-invasive assessment of pharmacokinetics and pharmacodynamics of therapeutic agents. Often the imaging techniques and targeting agents utilized are directly transferable to the clinical setting. The Animal Tumor Models component of the SASC has established patient-derived xenograft (PDX) models of breast, colorectal, lung, sarcoma, and gastric cancers in collaboration with COHCCC physician scientists and has developed next-generation humanized mouse models for research in cancer immunotherapy and in vivo drug metabolism/toxicity studies. The development of PDX models supports precision medicine by allowing investigators to evaluate tumor growth and therapeutic response for individual patients. The Animal Tumor Models component also provides specialized drug delivery services, training for in vivo procedures, and support for protocol preparation and grant development. The SASC is co-directed by Dr. David Colcher, a Professor in the Department of Molecular Immunology, and Dr. Jun Wu, an Associate Research Professor of Comparative Medicine, and is supported by highly qualified staff that maintain and operate the instrumentation. Oversight is provided by an interdisciplinary faculty Advisory Committee, and user feedback through an annual survey. The SASC occupies three rooms within the 29,000 sq. ft. Parvin Building for animal experiments and two rooms in Huntington Lab for tumor cell and reagent preparation. iLab software is used to schedule services, monitor instrument use, and manage billing within the SASC. Over the previous five years, the SASC was used by 80 unique investigators, including 58 CC members. Of the 58 CC members, 48 (83%) had peer-reviewed funding. As of this report, the SASC provides ongoing support to 12 NIH-funded projects totaling $5.6M per year in direct costs to the COHCCC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
Engineered anti-PSCA antibodies for immunoPET and targeted therapy of pancreatic cancer
(PQC4) Imaging CD8 T Cells In Tumor Immunotherapy By Immunopet
In vivo imaging of T Cells using engineered antibodies and PET
海外基金